Advertisement
U.S. Markets close in 2 hrs 28 mins

Aarti Drugs Limited (AARTIDRUGS.NS)

NSE - NSE Real Time Price. Currency in INR
488.60-6.40 (-1.29%)
At close: 03:30PM IST
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
3/31/2024
3/31/2023
3/31/2022
3/31/2021
3/31/2020
Total Revenue
24,228,100
25,285,800
27,160,500
24,886,458
21,547,798
-
Cost of Revenue
15,911,900
16,777,200
18,885,100
19,849,832
15,544,706
-
Gross Profit
8,316,200
8,508,600
8,275,400
5,036,626
6,003,092
-
Operating Expense
5,865,100
5,858,500
5,722,600
2,058,657
2,044,180
-
Operating Income
2,451,100
2,650,100
2,552,800
2,977,969
3,958,912
-
Net Non Operating Interest Income Expense
-336,900
-335,200
-332,900
-231,909
-236,349
-
Pretax Income
2,159,800
2,355,300
2,241,800
2,699,551
3,690,139
-
Tax Provision
590,800
639,400
578,200
649,593
886,156
-
Net Income Common Stockholders
1,568,100
1,714,200
1,663,100
2,050,386
2,804,130
-
Diluted NI Available to Com Stockholders
1,568,100
1,714,200
1,663,100
2,050,386
2,804,130
-
Basic EPS
19.49
18.56
17.97
22.14
30.09
-
Diluted EPS
19.49
18.56
17.97
22.14
30.09
-
Basic Average Shares
92,457
91,940
92,600
92,600
93,200
-
Diluted Average Shares
92,457
91,940
92,600
92,600
93,200
-
Rent Expense Supplemental
-
-
600
600
600
600
Total Expenses
21,777,000
22,635,700
24,607,700
21,908,489
17,588,886
-
Net Income from Continuing & Discontinued Operation
1,568,100
1,714,200
1,663,100
2,050,386
2,804,130
-
Normalized Income
1,568,100
1,714,200
1,663,100
2,063,193
2,808,856
-
Interest Income
-
-
6,992
7,169
25,958
11,257
Interest Expense
336,900
335,200
332,900
207,480
229,574
-
Net Interest Income
-336,900
-335,200
-332,900
-231,909
-236,349
-
EBIT
2,496,700
2,690,500
2,574,700
2,907,031
3,919,713
-
EBITDA
3,019,000
3,205,000
3,077,900
3,407,520
4,418,548
-
Reconciled Cost of Revenue
15,911,900
16,777,200
18,885,100
19,849,832
15,544,706
-
Reconciled Depreciation
522,300
514,500
503,200
500,489
498,835
-
Net Income from Continuing Operation Net Minority Interest
1,568,100
1,714,200
1,663,100
2,050,386
2,804,130
-
Total Unusual Items Excluding Goodwill
0
0
0
-16,865
-6,219
-
Total Unusual Items
0
0
0
-16,865
-6,219
-
Normalized EBITDA
3,019,000
3,205,000
3,077,900
3,424,385
4,424,767
-
Tax Rate for Calcs
0
0
0
0
0
-
Tax Effect of Unusual Items
0
0
0
-4,058
-1,493
-